Poncirin Inhibits Osteoclast Differentiation and Bone Loss through Down-Regulation of NFATc1 In Vitro and In Vivo |
Chun, Kwang-Hoon
(Gachon Institute of Pharmaceutical Sciences, College of Pharmacy, Gachon University)
Jin, Hyun Chul (Lab of Cell Differentiation Research, College of Oriental Medicine, Gachon University) Kang, Ki Sung (Lab of Cell Differentiation Research, College of Oriental Medicine, Gachon University) Chang, Tong-Shin (College of Pharmacy, Seoul National University) Hwang, Gwi Seo (Lab of Cell Differentiation Research, College of Oriental Medicine, Gachon University) |
1 | Islam, S., Hassan, F., Tumurkhuu, G., Dagvadorj, J., Koide, N., Naiki, Y., Mori, I., Yoshida, T. and Yokochi, T. (2007) Bacterial lipopolysaccharide induces osteoclast formation in RAW 264.7 macrophage cells. Biochem. Biophys. Res. Commun. 360, 346-351. DOI |
2 | Jang, Y., Kim, E. K. and Shim, W. S. (2018) Phytotherapeutic effects of the fruits of Poncirus trifoliata (L.) Raf. on cancer, inflammation, and digestive dysfunction. Phytother. Res. 32, 616-624. DOI |
3 | Jang, Y., Kim, T. K. and Shim, W. S. (2013) Naringin exhibits in vivo prokinetic activity via activation of ghrelin receptor in gastrointestinal motility dysfunction rats. Pharmacology 92, 191-197. DOI |
4 | Kim, J., Lee, H., Kang, K. S., Chun, K. H. and Hwang, G. S. (2015) Cordyceps militaris mushroom and cordycepin inhibit RANKL-induced osteoclast differentiation. J. Med. Food 18, 446-452. DOI |
5 | Kim, J. B., Han, A. R., Park, E. Y., Kim, J. Y., Cho, W., Lee, J., Seo, E. K. and Lee, K. T. (2007) Inhibition of LPS-induced iNOS, COX-2 and cytokines expression by poncirin through the NF-kappaB inactivation in RAW 264.7 macrophage cells. Biol. Pharm. Bull. 30, 2345-2351. DOI |
6 | Kim, J. H. and Kim, N. (2014) Regulation of NFATc1 in osteoclast differentiation. J. Bone Metab. 21, 233-241. DOI |
7 | Lee, Y. M., Kim, C. Y., Kim, Y. C. and Kim, H. M. (1997) Effects of Poncirus trifoliata on type I hypersensitivity reaction. Am. J. Chin. Med. 25, 51-56. DOI |
8 | Lee, Y. M., Kim, D. K., Kim, S. H., Shin, T. Y. and Kim, H. M. (1996) Antianaphylactic activity of Poncirus trifoliata fruit extract. J. Ethnopharmacol. 54, 77-84. DOI |
9 | Manolagas, S. C. (2000) Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr. Rev. 21, 115-137. DOI |
10 | Matsuo, K., Owens, J. M., Tonko, M., Elliott, C., Chambers, T. J. and Wagner, E. F. (2000) Fosl1 is a transcriptional target of c-Fos during osteoclast differentiation. Nat. Genet. 24, 184-187. DOI |
11 | Monje, P., Hernandez-Losa, J., Lyons, R. J., Castellone, M. D. and Gutkind, J. S. (2005) Regulation of the transcriptional activity of c-Fos by ERK. A novel role for the prolyl isomerase PIN1. J. Biol. Chem. 280, 35081-35084. DOI |
12 | Roodman, G. D. (1999) Cell biology of the osteoclast. Exp. Hematol. 27, 1229-1241. DOI |
13 | Shin, T. Y., Oh, J. M., Choi, B. J., Park, W. H., Kim, C. H., Jun, C. D. and Kim, S. H. (2006) Anti-inflammatory effect of Poncirus trifoliata fruit through inhibition of NF-kappaB activation in mast cells. Toxicol. In Vitro 20, 1071-1076. DOI |
14 | Smith, B. J., Lerner, M. R., Bu, S. Y., Lucas, E. A., Hanas, J. S., Lightfoot, S. A., Postier, R. G., Bronze, M. S. and Brackett, D. J. (2006) Systemic bone loss and induction of coronary vessel disease in a rat model of chronic inflammation. Bone 38, 378-386. DOI |
15 | Soysa, N. S. and Alles, N. (2009) NF-kappaB functions in osteoclasts. Biochem. Biophys. Res. Commun. 378, 1-5. DOI |
16 | Vaananen, H. K., Zhao, H., Mulari, M. and Halleen, J. M. (2000) The cell biology of osteoclast function. J. Cell Sci. 113, 377-381. DOI |
17 | Boyle, W. J., Simonet, W. S. and Lacey, D. L. (2003) Osteoclast differentiation and activation. Nature 423, 337-342. DOI |
18 | Wang, Z. Q., Ovitt, C., Grigoriadis, A. E., Mohle-Steinlein, U., Ruther, U. and Wagner, E. F. (1992) Bone and haematopoietic defects in mice lacking c-fos. Nature 360, 741-745. DOI |
19 | Wittrant, Y., Theoleyre, S., Couillaud, S., Dunstan, C., Heymann, D. and Redini, F. (2003) Regulation of osteoclast protease expression by RANKL. Biochem. Biophys. Res. Commun. 310, 774-778. DOI |
20 | Asagiri, M., Sato, K., Usami, T., Ochi, S., Nishina, H., Yoshida, H., Morita, I., Wagner, E. F., Mak, T. W., Serfling, E. and Takayanagi, H. (2005) Autoamplification of NFATc1 expression determines its essential role in bone homeostasis. J. Exp. Med. 202, 1261-1269. DOI |
21 | Yoon, H. Y., Yun, S. I., Kim, B. Y., Jin, Q., Woo, E. R., Jeong, S. Y. and Chung, Y. S. (2011) Poncirin promotes osteoblast differentiation but inhibits adipocyte differentiation in mesenchymal stem cells. Eur. J. Pharmacol. 664, 54-59. DOI |
22 | Wu, C. C., Hsu, S. C., Shih, H. M. and Lai, M. Z. (2003) Nuclear factor of activated T cells c is a target of p38 mitogen-activated protein kinase in T cells. Mol. Cell. Biol. 23, 6442-6454. DOI |
23 | Wu, H., Qi, H., Iwasaki, D., Zhu, B., Shimoishi, Y., Murata, Y. and Nakamura, Y. (2009) JNK-dependent NFATc1 pathway positively regulates IL-13 gene expression induced by (-)-epigallocatechin- 3-gallate in human basophilic KU812 cells. Free Radic. Biol. Med. 47, 1028-1038. DOI |
24 | Yoon, H. Y., Won, Y. Y. and Chung, Y. S. (2012) Poncirin prevents bone loss in glucocorticoid-induced osteoporosis in vivo and in vitro. J. Bone Miner. Metab. 30, 509-516. DOI |
25 | Hayward, M. and Fiedler-Nagy, C. (1987) Mechanisms of bone loss: rheumatoid arthritis, periodontal disease and osteoporosis. Agents Actions 22, 251-254. DOI |
26 | Choi, S. W., Park, K. I., Yeon, J. T., Ryu, B. J., Kim, K. J. and Kim, S. H. (2014) Anti-osteoclastogenic activity of matairesinol via suppression of p38/ERK-NFATc1 signaling axis. BMC Complement. Altern. Med. 14, 35. DOI |
27 | Eferl, R., Hoebertz, A., Schilling, A. F., Rath, M., Karreth, F., Kenner, L., Amling, M. and Wagner, E. F. (2004) The Fos-related antigen Fra-1 is an activator of bone matrix formation. EMBO J. 23, 2789-2799. DOI |
28 | Fujisaki, K., Tanabe, N., Suzuki, N., Kawato, T., Takeichi, O., Tsuzukibashi, O., Makimura, M., Ito, K. and Maeno, M. (2007) Receptor activator of NF-kappaB ligand induces the expression of carbonic anhydrase II, cathepsin K, and matrix metalloproteinase-9 in osteoclast precursor RAW264.7 cells. Life Sci. 80, 1311-1318. DOI |
29 | Fukuda, A., Hikita, A., Wakeyama, H., Akiyama, T., Oda, H., Nakamura, K. and Tanaka, S. (2005) Regulation of osteoclast apoptosis and motility by small GTPase binding protein Rac1. J. Bone Miner. Res. 20, 2245-2253. DOI |
30 | Grigoriadis, A. E., Wang, Z. Q., Cecchini, M. G., Hofstetter, W., Felix, R., Fleisch, H. A. and Wagner, E. F. (1994) c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science 266, 443-448. DOI |
31 | Huang, H., Chang, E. J., Ryu, J., Lee, Z. H., Lee, Y. and Kim, H. H. (2006) Induction of c-Fos and NFATc1 during RANKL-stimulated osteoclast differentiation is mediated by the p38 signaling pathway. Biochem. Biophys. Res. Commun. 351, 99-105. DOI |
32 | Ikeda, F., Matsubara, T., Tsurukai, T., Hata, K., Nishimura, R. and Yoneda, T. (2008) JNK/c-Jun signaling mediates an anti-apoptotic effect of RANKL in osteoclasts. J. Bone Miner. Res. 23, 907-914. DOI |